Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Cheng Zhu
Cheng Zhu, Kanagawa JP
| Patent application number | Description | Published |
|---|---|---|
| 20100144083 | METHOD OF MANUFACTURING PHOTOELECTRIC CONVERSION DEVICE - The present invention relates to a method of manufacturing a photoelectric conversion device in which selective dye adsorption can be performed easily. In the step of a dye adsorbing process, a material unit | 06-10-2010 |
| 20110083719 | ELECTRONIC DEVICE - The present invention relates to an electronic device configured to make use of features in terms of design quality and flexibility of a dye-sensitized solar cell. A solar cell-cum-display unit | 04-14-2011 |
| 20110155223 | DYE-SENSITIZED SOLAR CELL AND A METHOD OF MANUFACTURING THE SAME - The present invention provides a dye-sensitized solar cell which can obtain a high photoelectric conversion efficiency, which can be manufactured at a low cost, and which is superior in a design property, and a method of manufacturing the same. Dye supporting porous titanium oxide layers | 06-30-2011 |
Cheng Zhu, Edison, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090253705 | HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS - The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor. | 10-08-2009 |
| 20110028461 | HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS - The present invention provides compounds of Formula I, pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor. | 02-03-2011 |
| 20110028481 | HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS - The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor. | 02-03-2011 |
Cheng Zhu, Scotch Plains, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090118300 | Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators - Certain novel substituted imidazole 4-carboxamides are ligands of the human cholecystokinin receptor and, in particular, are selective ligands of the human cholecystokinin-1 receptor (CCK-1R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1R, such as obesity, and diabetes. | 05-07-2009 |
| 20090239862 | Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators - Certain novel substituted imidazole 4-carboxamides are ligands of the human cholecystokinin receptor and, in particular, are selective ligands of the human cholecystokinin-1 receptor (CCK-1R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1, such as obesity, and diabetes. | 09-24-2009 |
| 20090281117 | Substituted Imidazole-4-Carboxamides as Cholecystokinin -1 Receptor Modulators - Certain novel substituted imidazole 4-carboxamides are ligands of the human cholecystokinin receptor and, in particular, are selective ligands of the human cholecystokinin-1 receptor (CCK-1R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1R, such as obesity, and diabetes. | 11-12-2009 |